Skip to content

Clinical trials

Phase 2 Ataxia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ataxia Phase: Phase 2 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20121
20132
20161
20181
20201
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)2
Neuren Pharmaceuticals Limited2
Cadent Therapeutics1
Cairo University1
Federico II University1
PTC Therapeutics1
Sara Elva Espinosa Padilla, MD1
Seoul National University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ataxia10
Friedreich Ataxia3
Autistic Disorder2
Cerebellar Ataxia2
Rett Syndrome2
Spinocerebellar Ataxias2
Ataxia Telangiectasia1
Machado-Joseph Disease1
Medulloblastoma1
Spinocerebellar Degenerations1

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.